JBTM insider to sell 30,000 shares under Rule 144 filing
JBTM has a Form 144 filing indicating an intended sale of 30,000 shares of common stock through The Charles Schwab Corporation on or after 11/26/2025 on the NYSE.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
JBTM has a Form 144 filing indicating an intended sale of 30,000 shares of common stock through The Charles Schwab Corporation on or after 11/26/2025 on the NYSE. The planned sale has an aggregate market value of $4,326,864, while 51,971,372 shares of the issuer’s stock are reported as outstanding. The seller acquired these 30,000 shares on 01/02/2025 in a stock merger transaction with the issuer. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about JBTM’s current or future operations.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the JBTM Form 144 filing disclose?
The filing discloses that a JBTM affiliate plans to sell 30,000 shares of common stock under Rule 144, using The Charles Schwab Corporation as broker on the NYSE.
When is the JBTM Form 144 sale expected to occur?
The Form 144 lists an approximate date of sale of 11/26/2025 for the planned disposition of the 30,000 JBTM shares.
What representation does the seller make in the JBTM Form 144?
The seller represents that they do not know of any material adverse information about JBTM’s current or prospective operations that has not been publicly disclosed.
AI-generated analysis. How Rhea-AI works. Not financial advice.